524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹39
- High
- ₹45
- 52 Week Low
- ₹27
- 52 Week High
- ₹48
- Open Price₹42
- Previous Close₹42
- Volume2,437
- 50 DMA₹39.55
- 100 DMA₹39.34
- 200 DMA₹38.27
Investment Returns
- Over 1 Month -2.73%
- Over 3 Month + 33.96%
- Over 6 Month + 5.38%
- Over 1 Year -15.62%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 89.3
- PEG Ratio
- 1.4
- Market Cap Cr
- 57
- P/B Ratio
- 2.1
- Average True Range
- 3.61
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.03
- RSI
- 48.93
- MFI
- 29.93
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹39.60
-2.39
(-5.69%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹39.92
- 50 Day
- ₹39.55
- 100 Day
- ₹39.34
- 200 Day
- ₹38.27
Resistance and Support
41.3
- R3 48.78
- R2 46.89
- R1 43.19
- S1 37.60
- S2 35.71
- S3 32.01
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹39 As on 12 February, 2026 | 05:06
The Market Cap of Bacil Pharma is ₹56.8 Cr As on 12 February, 2026 | 05:06
The P/E ratio of Bacil Pharma is 89.3 As on 12 February, 2026 | 05:06
The PB ratio of Bacil Pharma is 2.1 As on 12 February, 2026 | 05:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.